Gainers
- Aileron Therapeutics ALRN shares rose 27.9% to $0.22 during Friday's after-market session. This security traded at a volume of 6.5 million shares come close, making up 1454.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $19.9 million.
- Aspira Womens Health AWH stock increased by 9.57% to $1.03. The company's market cap stands at $115.5 million.
- NeuroOne Medical Tech NMTC shares rose 7.55% to $1.85. This security traded at a volume of 297.6K shares come close, making up 170.9% of its average volume over the last 100 days. The company's market cap stands at $29.9 million.
- Biotricity BTCY shares moved upwards by 6.55% to $1.3. The company's market cap stands at $65.3 million.
- Scopus BioPharma SCPS stock rose 6.51% to $0.44. The market value of their outstanding shares is at $9.2 million.
- Kiora Pharmaceuticals KPRX stock rose 6.31% to $0.16. Kiora Pharmaceuticals's trading volume hit 516.0K shares by close, accounting for 62.4% of its average volume over the last 100 days. The company's market cap stands at $5.8 million.
Losers
- AlerisLife ALR stock fell 9.9% to $1.54 during Friday's after-market session. The market value of their outstanding shares is at $50.2 million. As per the press release, Q2 earnings came out 2 days ago.
- Athenex ATNX shares declined by 7.91% to $0.88. Today's trading volume for this security ended up closing at 3.5 million shares, which is 316.2 percent of its average volume over the last 100 days. The company's market cap stands at $106.9 million.
- Statera BioPharma STAB shares fell 7.85% to $0.23. The company's market cap stands at $11.7 million.
- InVivo Therapeutics Hldg NVIV stock declined by 7.37% to $8.3. This security traded at a volume of 148.2K shares come close, making up 24.2% of its average volume over the last 100 days. The company's market cap stands at $11.5 million.
- Allakos ALLK shares declined by 7.27% to $3.7. The company's market cap stands at $202.6 million. As per the news, the Q2 earnings report came out yesterday.
- Evofem Biosciences EVFM stock declined by 6.73% to $0.88. Today's trading volume for this security ended up closing at 6.4 million shares, which is 19.2 percent of its average volume over the last 100 days. The company's market cap stands at $31.1 million. As per the news, the Q2 earnings report came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in